Merck & Company, Inc. vs Insulet Corporation — Stock Comparison

MRK
Merck & Company, Inc.
$112.16
▲ 2.73%
vs
PODD
Insulet Corporation
$175.04
▲ 1.68%
Q·Score Winner
Insulet Corporation
PODD7.8/10vs 6.7/10

Q·Score Breakdown

6.7
Neutral
Overall
7.8
Bullish
6.2
Quality
6.4
7
Health
7.9
6.2
Growth
8
7.2
Valuation
9.1
7.1
Sentiment
8.1
MRK

Forward P/E of 11.5× is low relative to sector peers.

PODD

Consensus analyst target of $326.35 is 86% above current price.

Analyst Consensus

BUY
Target $129.74 (+15.7%)
27 analysts
BUY
Target $326.35 (+86.4%)
23 analysts

Fundamentals

MRK
PODD
31.5×
Trailing P/E
50.3×
11.5×
Forward P/E
21.7×
13.6%
Profit Margin
9.1%
76.6%
Gross Margin
71.6%
ROE
18.1%
4.9%
Revenue Growth
31.2%
Earnings Growth
3.9%
0.28
Beta
1.47
Price / Book
$277.0B
Market Cap
$12.1B
$73 – $125
52-Week Range
$158 – $355

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →